121 related articles for article (PubMed ID: 18094415)
1. Mitochondrial resequencing arrays detect tumor-specific mutations in salivary rinses of patients with head and neck cancer.
Mithani SK; Smith IM; Zhou S; Gray A; Koch WM; Maitra A; Califano JA
Clin Cancer Res; 2007 Dec; 13(24):7335-40. PubMed ID: 18094415
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
Carvalho AL; Jeronimo C; Kim MM; Henrique R; Zhang Z; Hoque MO; Chang S; Brait M; Nayak CS; Jiang WW; Claybourne Q; Tokumaru Y; Lee J; Goldenberg D; Garrett-Mayer E; Goodman S; Moon CS; Koch W; Westra WH; Sidransky D; Califano JA
Clin Cancer Res; 2008 Jan; 14(1):97-107. PubMed ID: 18172258
[TBL] [Abstract][Full Text] [Related]
3. Whole mitochondrial genome screening in maternally inherited non-syndromic hearing impairment using a microarray resequencing mitochondrial DNA chip.
Lévêque M; Marlin S; Jonard L; Procaccio V; Reynier P; Amati-Bonneau P; Baulande S; Pierron D; Lacombe D; Duriez F; Francannet C; Mom T; Journel H; Catros H; Drouin-Garraud V; Obstoy MF; Dollfus H; Eliot MM; Faivre L; Duvillard C; Couderc R; Garabedian EN; Petit C; Feldmann D; Denoyelle F
Eur J Hum Genet; 2007 Nov; 15(11):1145-55. PubMed ID: 17637808
[TBL] [Abstract][Full Text] [Related]
4. Decreased mitochondrial DNA content in posttreatment salivary rinses from head and neck cancer patients.
Jiang WW; Rosenbaum E; Mambo E; Zahurak M; Masayesva B; Carvalho AL; Zhou S; Westra WH; Alberg AJ; Sidransky D; Koch W; Califano JA
Clin Cancer Res; 2006 Mar; 12(5):1564-9. PubMed ID: 16533782
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD44 is a potential marker for the early detection of head and neck cancer.
Franzmann EJ; Reategui EP; Pedroso F; Pernas FG; Karakullukcu BM; Carraway KL; Hamilton K; Singal R; Goodwin WJ
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1348-55. PubMed ID: 17627000
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial mutations are a late event in the progression of head and neck squamous cell cancer.
Mithani SK; Taube JM; Zhou S; Smith IM; Koch WM; Westra WH; Califano JA
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4331-5. PubMed ID: 17671113
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing.
Coon KD; Valla J; Szelinger S; Schneider LE; Niedzielko TL; Brown KM; Pearson JV; Halperin R; Dunckley T; Papassotiropoulos A; Caselli RJ; Reiman EM; Stephan DA
Mitochondrion; 2006 Aug; 6(4):194-210. PubMed ID: 16920408
[TBL] [Abstract][Full Text] [Related]
8. Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development.
Smith IM; Mithani SK; Liu C; Chang SS; Begum S; Dhara M; Westra W; Sidranksy D; Califano JA
Arch Otolaryngol Head Neck Surg; 2009 May; 135(5):487-95. PubMed ID: 19451471
[TBL] [Abstract][Full Text] [Related]
9. Salivary soluble CD44: a potential molecular marker for head and neck cancer.
Franzmann EJ; Reategui EP; Carraway KL; Hamilton KL; Weed DT; Goodwin WJ
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):735-9. PubMed ID: 15767360
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma.
Lièvre A; Blons H; Houllier AM; Laccourreye O; Brasnu D; Beaune P; Laurent-Puig P
Br J Cancer; 2006 Mar; 94(5):692-7. PubMed ID: 16495928
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients.
Rettori MM; de Carvalho AC; Bomfim Longo AL; de Oliveira CZ; Kowalski LP; Carvalho AL; Vettore AL
Carcinogenesis; 2013 Jan; 34(1):20-7. PubMed ID: 23042095
[TBL] [Abstract][Full Text] [Related]
12. An oligonucleotide microarray for high-throughput sequencing of the mitochondrial genome.
Zhou S; Kassauei K; Cutler DJ; Kennedy GC; Sidransky D; Maitra A; Califano J
J Mol Diagn; 2006 Sep; 8(4):476-82. PubMed ID: 16931588
[TBL] [Abstract][Full Text] [Related]
13. Analysis of potential cancer biomarkers in mitochondrial DNA.
Jakupciak JP; Dakubo GD; Maragh S; Parr RL
Curr Opin Mol Ther; 2006 Dec; 8(6):500-6. PubMed ID: 17243485
[TBL] [Abstract][Full Text] [Related]
14. Nonsynonymous somatic mitochondrial mutations occur in the majority of cutaneous melanomas.
Mithani SK; Smith IM; Topalian SL; Califano JA
Melanoma Res; 2008 Jun; 18(3):214-9. PubMed ID: 18477896
[TBL] [Abstract][Full Text] [Related]
15. Validation of microarray-based resequencing of 93 worldwide mitochondrial genomes.
Hartmann A; Thieme M; Nanduri LK; Stempfl T; Moehle C; Kivisild T; Oefner PJ
Hum Mutat; 2009 Jan; 30(1):115-22. PubMed ID: 18623076
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions.
Kim MM; Clinger JD; Masayesva BG; Ha PK; Zahurak ML; Westra WH; Califano JA
Clin Cancer Res; 2004 Dec; 10(24):8512-5. PubMed ID: 15623632
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
[TBL] [Abstract][Full Text] [Related]
18. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation.
Ha PK; Tong BC; Westra WH; Sanchez-Cespedes M; Parrella P; Zahurak M; Sidransky D; Califano JA
Clin Cancer Res; 2002 Jul; 8(7):2260-5. PubMed ID: 12114429
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
Murugan AK; Hong NT; Fukui Y; Munirajan AK; Tsuchida N
Int J Oncol; 2008 Jan; 32(1):101-11. PubMed ID: 18097548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
